COMMUNIQUÉS West-GlobeNewswire

Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one [...]
LeMaitre to Participate at Upcoming Investor Conferences in June
20/05/2026
BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare [...]
Nanobiotix annonce le lancement d’une offre globale
21/05/2026
Paris, France ; Cambridge, Massachusetts (USA), 20 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase [...]
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress
20/05/2026
Conference call and webcast to discuss results to be held on June 22, 2026 at 8 a.m. ET IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
20/05/2026
Jupiter, FL, May 20, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage biopharmaceutical company focused on central nervous system disorders and [...]
FDA Warns Retailers Selling Illegal Tobacco Products That Look Like Everyday Products
20/05/2026
Agency takes action to combat unauthorized tobacco products resembling candy, breath strips, and cough drops Silver Spring, MD, May 20, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration announced today that [...]
AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement
20/05/2026
OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at- [...]
Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close
20/05/2026
Alongside a national brand modernization effort, Ronald McDonald House New England is preparing to embark on a bold new chapter—one that will meaningfully expand their ability to support families navigating pediatric [...]
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
20/05/2026
agenT-797 demonstrates pathogen suppression, lung immune restoration and tissue repair activation, supporting Ongoing Phase 2 trial Sequential immunotherapy with agenT-797 and N-803, an FDA-approved IL-15 superagonist, [...]
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
20/05/2026
Testo Prime Launched Safe and Natural Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Read User Guide to Best Result For Energy, Stamina and Performance New York City, May 20, 2026 (GLOBE NEWSWIRE) -- IN [...]
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
20/05/2026
MALVERN, Pa., May 20, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Regional Health Properties Reports First Quarter 2026 Results
20/05/2026
Reported First Quarter Revenue of $21.2 million Generated Adjusted EBITDA from Operations of $0.5 million Continued Execution of Integrated Healthcare Platform Strategy ATLANTA, GA, May 20, 2026 (GLOBE NEWSWIRE) -- [...]
Glass House Brands to Host Investor Sesh V on Thursday, June 18, 2026
20/05/2026
Company to Hold its Fifth Annual ‘Investor Sesh’ in Appreciation of Investor Support and in Commitment to Transparency for Shareholders LONG BEACH, Calif. and TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- Glass House Brands [...]
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
20/05/2026
MELBOURNE, Australia, May 20, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq”) today announced the commencement of its first clinical trial for an antiparasitic drug candidate powered by Gelteq ® technology, marking a [...]
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
20/05/2026
31 vonoprazan-related clinical abstracts presented at Digestive Disease Week (DDW) 2026, including 28 independent analyses across GI conditions and three Phathom-sponsored clinical research abstracts Independent [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
20/05/2026
BOSTON, May 20, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that [...]
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
20/05/2026
Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026 Shetty is IM8’s first global ambassador from [...]

Pages